B-Cell Depletion Therapy May Be Effective

B-Cell Depletion Therapy May Be Effective

284205

B-Cell Depletion Therapy May Be Effective

Intensified B-cell depletion therapy (IBCDT) — administering immunosuppressants to lower the number of antibody-producing immune B-cells — may be a promising strategy to help people with scleroderma manage their condition, a study shows. IBCDT may be particularly helpful for those with extensive skin involvement and severe interstitial lung disease (ILD), and eventually may eliminate the need for long-term treatment with conventional immunosuppressants, scientists said. The study, “A 3-Year Observational Study of Patients with Progressive Systemic…

You must be logged in to read/download the full post.